State-of-the-art Enzyme Manufacturing
Large scale contract manufacturing and routine supply of commercial enzymes
Flexible fermentation partner for large-scale enzyme manufacturing
Our state-of-the-art manufacturing facilities are designed to support the large-scale production of high-quality life science enzymes. Equipped with advanced fermentation systems and downstream processing capabilities, we offer scalable solutions that ensure consistency, purity, and efficiency at every stage of production. With capacities reaching up to 10,000L on site, our cutting-edge facilities are built to meet the most demanding requirements of the life science industry, enabling rapid scale-up from development to full commercial manufacturing while maintaining the highest standards of quality and compliance.
Enzyme Manufacturing Plant:
ISO 9001 fully certified manufacturing facility
Pilot Plant Scale 70 - 750L Fermentation
Large-scale 10,000L Fermentation
Large scale freeze drying
European Fermentation Network:
50m3+ Production Plant
Types of Downstream Processing:
Homogenisation
Centrifugation
Depth Filtration
Ultrafiltration
Phase Separation
Bactofiltration
Chromatography (IEX, Affinity, HIC etc.)
Freeze-drying on site
Spray-drying off site
11 Dec 2024
Biocatalysts Ltd and GOA Ventures announce long-term partnership to develop innovative enzymes for utilisation of seaweed
A long-term strategic collaboration aimed at accelerating sustainable protein and renewable energy solutions using seaweed, ultimately reducing the dependency on fossil-based raw materials and representing a significant advancement in eco-friendly valorisation of seaweed.
25 Nov 2024
Food Ingredients Europe 2024: Key Highlights and Trends Shaping the Future of Food
As Food Ingredients Europe comes to a close for another year, we reflect back on the key trends from this year and what we can expect to see shaping the future of food ingredients.
18 Nov 2024
Biocatalysts Ltd Launches PlantPro™ enzyme range to address key challenges in the plant-based food industry
As consumer demand for plant-based products continues to rise, so do the challenges of creating foods that deliver on taste, texture, and functionality. This new brand will help our customers create standout products like plant-based beverages, dairy alternatives, meat substitutes, and cheese alternatives.
29 Oct 2024
Enhancing Enzyme Modified Dairy Ingredients with an Umami Boost
Glutamine is an amino acid found in protein -containing foods. Glutamine can be converted into glutamate and is one of the key factors in contributing a savoury umami taste sensation.
29 Oct 2024
Biocatalysts Ltd Launches Innovative Enzymes Solution to Boost Umami Flavour in Dairy Ingredients
Unique enzyme solution designed to enhance umami flavours in dairy ingredients. This new product combines unique enzyme activities to create rich, savoury profiles to differentiate your dairy ingredients.
1 Oct 2024
BRAIN Biotech AG and Biocatalysts Ltd Launch a New Business Initiative to Revolutionise Enzyme Solutions within the Life Science Industry
Combining cutting-edge enzyme discovery, optimisation, and large-scale manufacturing to offer an end-to-end solution for the life sciences industry. BRAIN-Biocatalysts Life Science Solutions addresses critical gaps in the market, providing tailored enzyme solutions with a transparent IP strategy that ensures partners retain full control over their innovations.
Application Solution
Unlocking the benefits of plant oil hydrolysis
Free fatty acids, the fundamental building blocks in many sectors, can vary in chain length and degree of saturation, influencing their functionality and applications. However, the industry has long faced challenges in maximising the yield of free fatty acids while maintaining cost efficiency and environmental sustainability.
16 Sept 2024
Biocatalysts Ltd Launches Lipomod™ 70MDP - Setting A New Standard To Deliver Sustainable Solutions for Oleochemicals Industry with Maximal Production Efficiency
Achieve superior hydrolysis unseen in the market for breaking down plant-derived oils into valuable by-products like glycerol and fatty acids
30 Aug 2024
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
BRAIN Biotech AG, a leading provider of integrated solutions for the biologisation of industry, today published its 9M results of FY2023/2024.
22 Aug 2024
BRAIN Biotech launches MetXtra™
Designed to establish and optimise biocatalytic processes, develop novel enzyme solutions and generate IP or FTO for customers, the cutting edge technologies of MetXtra™ unlock the secrets of the unexplored sequence space.
30 Jul 2024
Biocatalysts Ltd launches new "Plug & Produce" production strains significantly reducing scale-up time and cost
Developing enzyme and protein fermentation processes can be long and expensive and is often reliant on a single partner. Our proprietary "Plug & Produce" platform of microbial fermentation strains can bring product to market quicker, reduce cost and reduce supply chain risk.
23 Jul 2024
The Crucial Role of Phenylalanine Dehydrogenase in Detecting Phenylketonuria
Phenylketonuria (PKU) is genetic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase for the conversion of the amino acid, phenylalanine to tyrosine. This condition can cause phenylalanine accumulation in the blood and result in neurological damage if left untreated or undiagnosed. Read about the highly specific and sensitive enzymatic method for early detection of PKU.
